Host: Barnett Mennen, MD

Host Dr. Barry Mennen was joined by US Diabetes Experts to discuss Toujeo®, (insulin glargine injection) 300 units/mL, a long-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus. Toujeo® is not recommended for treating diabetic ketoacidosis. Dr. Barry Mennen welcomes: Dr. Timothy Gilbert, Clinical Endocrinologist at the Endocrinology Center of Southwest Louisiana, in Lake Charles, LA Advanced Practice Nurse and Certified Diabetes Educator - Deborah Hinnen, who is at the Memorial Hospital Diabetes Center part of the University of Colorado Health System, Colorado Springs, CO Dr. Udaya Kabadi, Adjunct Professor of Medicine at University of Iowa School of Medicine and an Endocrinologist involved in clinical research, Iowa City, IA Dr. Jeremy Pettus, Board-Certified Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego, CA Jodi Strong, Doctorate Nurse Practitioner and Diabetes Educator, who is with the Ministry Medical Group in Stevens Point, Wisconsin Dr. Carol Wysham, Clinical Endocrinologist and Section Head of Rockwood Center for Diabetes and Endocrinology, Spokane, WA Please click here for Full Prescribing Information for Toujeo® Important Safety Information for Toujeo® (insulin glargine injection) 300 units/mL ContraindicationsToujeo® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin ...